Markets & Regulations

© GettyImages/iLexx

BARDA and Locus in tie-up to tackle UTIs with phages

By Jane Byrne

Locus Biosciences has signed a contract with BARDA to co-fund development of LBP-EC01, a CRISPR Cas3-enhanced bacteriophage (crPhage) that targets E. coli bacteria causing recurrent urinary tract infections (UTIs).

Pic:getty/daniilantiq

Industry welcomes release of FDA COVID-19 vaccine guidance

By Rachel Arthur

On Tuesday the FDA released its guidance on Emergency Use Authorization for COVID-19 vaccines: a move welcomed by the industry as a ‘tried and true tradition of releasing guidance in a public and transparent way’.

Pic:getty/dilenua

Sartorius acquires BIA Separations for $423m

By Rachel Arthur

German life science company Sartorius will merge Slovenian purification specialist BIA Separations with Sartorius Stedim Biotech, in a deal worth €360m ($423m).

(Ca-ssis/iStock via Getty Images Plus)

CPhI Festival of Pharma

Vetter to profile cleanroom concept at CPhI

By Jenni Spinner

The aseptic technology specialist plans to discuss its V-CRT cleanroom technology at the upcoming CPhI Festival of Pharma online event in October.

(robeo/iStock via Getty Images Plus)

CPhI Festival of Pharma

Noble to address drug delivery evolution at CPhI

By Jenni Spinner

A leader from the pharma solutions firm will discuss the future of drug delivery at a keynote during the CPhI Festival of Pharma virtual event.

(gorodenkoff/iStock via Getty Images Plus)

CPhI Festival of Pharma

CPhI: SPI Pharma talks supply chain challenges

By Jenni Spinner

The pharma ingredients provider discusses new products, supply-chain obstacles, and what the future of the industry might hold, ahead of the online event.

Follow us

Products

View more

Webinars